Tpg Gp A, LLC Charles River Laboratories International, Inc. Transaction History

Tpg Gp A, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $11.2 Million - $16.3 Million	68,081 Added 18.93%	427,718 $101 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $6.06 Million - $6.78 Million	31,168 Added 9.49%	359,637 $70.5 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $5.95 Million - $6.81 Million	32,402 Added 10.94%	328,469 $69.1 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $1.19 Million - $1.61 Million	-6,196 Reduced 2.05%	296,067 $59.8 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $59.6 Million - $75.6 Million	302,263 New	302,263 $65.8 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.84B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Tpg Gp A, LLC, based on Form 13F filings with the SEC.

Stay updated on Tpg Gp A, LLC with notifications on news.